415 Capital Asset Manager Profile - aVenture Research
415 Capital is a specialist venture capital firm focusing on early- and development-stage MedTech companies in Europe, the United States, and Israel. Their primary investment focus is on innovative medical device technologies addressing cardiovascular disease, recognizing it as a leading global health concern and major healthcare cost driver. Typical investments span from seed to Series D rounds.
The firm boasts a strong track record, having funded over 45 MedTech companies and achieved multiple successful exits through trade sales and IPOs. 415 Capital offers portfolio companies not only capital but also clinical, scientific, and business expertise, along with market access. Notable investments include Moray Medical, R3 Vascular, and Supira Medical, demonstrating their commitment to funding breakthrough medical innovations.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.